Latest Updates
First Quarter 2010 Targets in Oncology Updates and Additions
- 3-Phosphoinositide-dependent kinase-1 (PDPK1)
- Androgen receptor (Ar)
- Bombesin receptor family
- Breast Cancer 1 (BRCA1)
- CREB regulated transcription coactivator 2 (CRTC2)
- Cyclin D binding myb-like transcription factor 1 (DMTF1)
- Dickkopf (DKK) family
- Forkhead box A1 (FOXA1)
- Forkhead box M1 (FOXM1)
- Heat shock 70kDa protein 5 (HSPA5)
- Histone deacetylase 6 (HDAC6)
- Hypoxia inducible factor 1 alpha (HIF1A)
- Protein phosphatase 1D magnesium-dependent, delta isoform (PPM1D)
- Protein tyrosine kinase 2 beta (PTK2B)
- CD200
- Connective tissue growth factor (CTGF)
- Delta-like 4 (DLL4)
- EGF-like-domain, multiple 7 (EGFL7)
- Lamin A/C (LMNA)
- Mixed lineage leukemia (MLL)
- Murine double minute 2 (MDM2)
- Myeloid differentiation primary response gene 88 (MyD88)
- Neuropilin 1 (NRP1)
- Notch family
- Oncostatin M (OSM)
- Prostate stem cell antigen (PSCA)
- Seven in absentia homolog-1 (SIAH1)
- Toll-like receptor 9 (TLr9)
- V-raf murine sarcoma viral oncogene homolog B1 (BRAF)
|
|
NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE: 1-949-830-0448 FAX: 1-949-830-0887
INFO@NEWMEDINC.COM
|